<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02784353</url>
  </required_header>
  <id_info>
    <org_study_id>PReHeBP</org_study_id>
    <secondary_id>2015-665</secondary_id>
    <nct_id>NCT02784353</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy</brief_title>
  <acronym>PReHeBP</acronym>
  <official_title>Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP(Hepatobiliary and Pancreatic) Malignancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP
      Malignancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most important outcome in the management of HBP malignancies is survival. Since the
      application of ERAS (enhanced recovery after surgery), the improvement of QOL(quality of
      life) has been known as one of important factor for the management of HBP malignancies as
      well as survival, and the improvement of QOL, itself, affect the survival.

      There are several reports that perioperative rehabilitation affect positively for the outcome
      of surgery and QOL in surgical patients. However, in the HBP field, there are rarely studied
      for this concept.

      This study aim to investigate that the application of rehabilitation program for the surgery
      of HBP malignancies affect on short-term outcome and lead the improvement of QOL.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 4, 2016</start_date>
  <completion_date type="Anticipated">October 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 arm, parallel, randomized controlled study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The result of allocation in control and intervention group would be blinded to primary and secondary outcomes assessor.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence and severity of general complication</measure>
    <time_frame>till postoperative 3 months</time_frame>
    <description>Incidence rate and severity of general complications except operation-specific complication, according to Clavien-Dindo classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of operation-specific complication</measure>
    <time_frame>till postoperative 3 months</time_frame>
    <description>Incidence rate and severity of operation-specific complication, according to Clavien-Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidende of Mortality</measure>
    <time_frame>till postoperative 3 months</time_frame>
    <description>Rate of in-hospital mortality and 90 days mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of re-admission</measure>
    <time_frame>till postoperative 3 months</time_frame>
    <description>the rate of re-admission, till postoperative 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes in Quality of life</measure>
    <time_frame>Comparison between at the time of discharge and postoperative 3months</time_frame>
    <description>changes in quality of life (EORTC QLQ-C30), at the time of discharge and 3 months after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance of Aerobic exercise, strength exercise and respiratory excursion (Changes in the parameters of rehabilitation)</measure>
    <time_frame>Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery</time_frame>
    <description>Compliance of Aerobic exercise, strength exercise and respiratory excursion based on exercise diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement on 6 minutes walk test (m/minute) (Changes in the parameters of rehabilitation)</measure>
    <time_frame>Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery</time_frame>
    <description>Measure the 6 minutes walk test (m/minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grasping power(dynamometer, kg)(Changes in the parameters of rehabilitation)</measure>
    <time_frame>Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery</time_frame>
    <description>Grasping power measurement using dynamometer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Hepatic Neoplasms</condition>
  <condition>Biliary Tract Neoplasms</condition>
  <condition>Pancreatic Neoplasms</condition>
  <arm_group>
    <arm_group_label>Conventional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No intervention; conventional perioperative management without perioperative rehabilitation program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention - PReHeBP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conventional perioperative management with preoperative and postoperative rehabilitation program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Perioperative rehabilitation program</intervention_name>
    <description>Perioperative rehabilitation program
preoperative rehabilitation : 2 weeks prior to operation
postoperative rehabilitation : 3 months after operation</description>
    <arm_group_label>Intervention - PReHeBP</arm_group_label>
    <other_name>PReHeBP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conventional</intervention_name>
    <description>conventional perioperative management without rehabilitation program</description>
    <arm_group_label>Conventional</arm_group_label>
    <other_name>No intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years old or &lt;80 years old

          -  ECOG 0-2

          -  resectable HBP malignancies or premalignant lesions which should be required GI
             resection and anastomosis

          -  open surgery

          -  no distant metastasis

          -  no functional disturbance in bone marrow; WBC at least 3,000/mm3 or absolute
             neutrophil count at least 1,500/mm3, Platelet count at least 125,000/mm3

          -  no functional disturbance in liver; AST less than 5 times upper limit of normal

          -  no function disturbance in kidney; Creatinine no greater than 1.5 times upper limit of
             normal

          -  informed consent

        Exclusion Criteria:

          -  distant metastasis (+) or recurred HBP tumor

          -  active or uncontrolled infection

          -  alcohol or other drug addiction

          -  already enrolled patient in other study which affect this study

          -  pregnant or the possibility of pregnancy (+)

          -  uncontrolled cardiopulmonary disease

          -  moderate to severe comorbidity which affect on the quality of life and nutritional
             status (liver cirrhosis, end stage renal disease, heart failure, etc.)

          -  previous history of major gastrointestinal surgery (gastrectomy, colectomy, etc.)

          -  previous history of neurological or musculoskeletal diseases which is impossible to
             allow investigator's order
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DAE WOOK HWANG, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center, University of Ulsan College of Medicine, SEOUL, KOREA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DAE WOOK HWANG, M.D.</last_name>
    <phone>82-2-3010-3939</phone>
    <email>dwhwang@amc.seoul.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>WON KIM, M.D.</last_name>
    <phone>82-2-3010-1694</phone>
    <email>duocl79@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asan Medical Center, University of Ulsan College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DAE WOOK HWANG, M.D.</last_name>
      <phone>82-2-3010-3939</phone>
      <email>dwhwang@amc.seoul.kr</email>
    </contact>
    <contact_backup>
      <last_name>WON KIM, M.D.</last_name>
      <phone>82-2-3010-1694</phone>
      <email>duocl79@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>DAE WOOK HWANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>WON KIM, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92-8.</citation>
    <PMID>5523831</PMID>
  </results_reference>
  <results_reference>
    <citation>Ford-Smith CD, Wyman JF, Elswick RK Jr, Fernandez T. Reliability of stationary dynamometer muscle strength testing in community-dwelling older adults. Arch Phys Med Rehabil. 2001 Aug;82(8):1128-32.</citation>
    <PMID>11494194</PMID>
  </results_reference>
  <results_reference>
    <citation>Johansson K, Tibe K, Weibull A, Newton RC. Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005 Dec;38(4):167-80.</citation>
    <PMID>16515225</PMID>
  </results_reference>
  <results_reference>
    <citation>Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015 Jun;39(6):1494-500. doi: 10.1007/s00268-015-2988-6.</citation>
    <PMID>25651963</PMID>
  </results_reference>
  <results_reference>
    <citation>Schwartz AL. Fatigue mediates the effects of exercise on quality of life. Qual Life Res. 1999 Sep;8(6):529-38.</citation>
    <PMID>10548868</PMID>
  </results_reference>
  <results_reference>
    <citation>Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. Gait speed and survival in older adults. JAMA. 2011 Jan 5;305(1):50-8. doi: 10.1001/jama.2010.1923.</citation>
    <PMID>21205966</PMID>
  </results_reference>
  <results_reference>
    <citation>Yeo TP, Burrell SA, Sauter PK, Kennedy EP, Lavu H, Leiby BE, Yeo CJ. A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg. 2012 Apr;214(4):463-75; discussion 475-7. doi: 10.1016/j.jamcollsurg.2011.12.017. Epub 2012 Feb 7.</citation>
    <PMID>22321518</PMID>
  </results_reference>
  <results_reference>
    <citation>Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004 May;13(4):863-8.</citation>
    <PMID>15129896</PMID>
  </results_reference>
  <results_reference>
    <citation>Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up &amp; Go Test. Phys Ther. 2000 Sep;80(9):896-903.</citation>
    <PMID>10960937</PMID>
  </results_reference>
  <results_reference>
    <citation>Bobbio A, Chetta A, Ampollini L, Primomo GL, Internullo E, Carbognani P, Rusca M, Olivieri D. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008 Jan;33(1):95-8. Epub 2007 Nov 19.</citation>
    <PMID>18006327</PMID>
  </results_reference>
  <results_reference>
    <citation>Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990 Jan-Feb;9(1-2):65-71; discussion 71-2.</citation>
    <PMID>2345839</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2016</study_first_submitted>
  <study_first_submitted_qc>May 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2016</study_first_posted>
  <last_update_submitted>July 7, 2017</last_update_submitted>
  <last_update_submitted_qc>July 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Dae Wook Hwang</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Rehabilitation</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Surgery</keyword>
  <keyword>Hepatic neoplasms</keyword>
  <keyword>Biliary tract neoplasms</keyword>
  <keyword>Pancreatic neoplasms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

